Cancer Grants

American Society of Preventive Oncology/
Prevent Cancer Foundation

2009 Cancer Prevention Research Fellowship
For Young Scientists at the Postdoctoral or Clinical Fellow Level

2009 Research Fellowship in Cancer Prevention Research: This Fellowship, sponsored by the Prevent Cancer Foundation, will provide a two-year award of $40,000 per year to a young scientist in the U.S. or engaged in meritorious cancer prevention research or presenting a proposal deemed to have potential for advancing the general goals of cancer prevention.

Letter of Intent
Each applicant is required to submit a very brief letter of intent (via e-mail, fax)  by November 14, 2008.

Eligibility
Candidates must have completed the MD, PhD, or other doctoral degree. Candidates must currently be a postdoctoral or clinical research fellow and must have been a fellow for at least one year but not more than 4 years prior to the year of the award. Academic faculty holding the rank of assistant professor or higher, graduate or medical students, federal government employees and employees of private industry are not eligible. A candidate need not be a member of the American Society of Preventive Oncology (ASPO) at the time of application, but must be nominated by an ASPO member. Student members may not be nominators.

Selection Process
Applications will receive careful scientific evaluation by a multidisciplinary committee consisting of ASPO members who are experts in basic and clinical cancer prevention research. Applications must be received in complete form by December 3, 2008.

An application can be found at www.aspo.org

American Head and Neck Society/American Academy of Otolaryngology - Head and Neck Surgery Young Investigator Combined Award

Open to new full time academic surgeons working on contemporary basic or clinical research skills focused on neoplastic disease of the head and neck in the U.S. or Canada. Two year, non-renewable, $40,000 maximum ($20,000 per year), one available annually.

The purpose of this award is to support a collaborative AHNS/AAO-HNSF research project by fostering
the development of contemporary basic or clinical research skills focused on neoplastic disease of the
head and neck among new full-time academic surgeons. The award is intended as a preliminary step in
clinical investigator career development and is expected to facilitate the recipient’s preparation of a more
comprehensive individualized research plan suitable for submission to the National Institutes of Health or
comparable funding agency.
ELIGIBILITY
Applicants must be physicians with demonstrated potential for excellence in research and teaching and
serious commitment to an academic research career in head and neck surgery. Applicants must be
members or candidate members of the American Academy of Otolaryngology-Head and Neck Surgery
and/or the American Head and Neck Society. Priority will be given to fellows or junior faculty who have
completed residencies or fellowships within four years of the application receipt date. All candidates
must be sponsored by the Chair of his/her Division or Department and by an official representative of the
institution which would administer the Award and in whose name the application is formally submitted.
Former ASHNS/AHNS or Foundation research grant recipients are eligible to compete for the
AHNS/AAO-HNSF grant. Individuals who have already competed successfully for independent research
grant support from a private or Federal funding agency are ineligible for this Award.
CONDITIONS
Research supported by this award should be specifically directed toward the pathophysiology, diagnosis,
prevention, or treatment of head and neck neoplastic disease, and may be either basic or
clinical/transnational in approach. Proposed projects shall be designed in collaboration with a preceptor
investigator and approved by the candidate's department chairperson and institution. While not
specifically required, proposals which aim to introduce new knowledge and methodology from other
disciplines to research in head and neck disease, or which demonstrate collaborative effort with members
of other related disciplines are encouraged. Projects must be designed so as to yield useful information
within the period of award, but priority will be given to projects that are also innovative with promise to
develop into new long-range or expanded research programs capable of attracting funding from other
sources. Applications must be accompanied by a letter of support from the applicant’s Department Chair
and Preceptor verifying that the applicant will be permitted to devote an appropriate amount of time to the
conduct and timely completion of the proposed research project. Applicants must obtain letters of
support/understanding from all key personnel on the project. The grantee must submit an interim
progress report to the Foundation at the end of the first year of the award.
TERMS
1. Amount: $40,000 maximum ($20,000 per year)
2. Period: 24 months, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

American Head and Neck Society Alando J. Ballantyne Resident Research Pilot Grant

For the best grant application by a resident in the U.S. or Canada. One year, non-renewable, $10,000, one available annually.

The purpose of this award is to support basic, translational, or clinical research projects in head and neck
oncology. Clinical or translational research studies are strongly encouraged and should be specifically
related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck
neoplastic disease. The Alando J. Ballantyne Resident Research Pilot Grant memorializes Alando J.
Ballantyne, M.D., a giving teacher, dedicated surgeon, and a devoted husband and father.
ELIGIBILITY
This grant is open to resident in U.S. or Canadian training programs. Previous AHNS or AAO-HNS
Foundation research grant recipients are eligible to compete for this grant. However, candidates who
have successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHNS must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may be
either basic or clinical/translational in approach. While not specifically required, proposals which aim to
introduce new knowledge and methodology from other disciplines to research in head and neck disease,
or which demonstrate collaborative effort with members of other related disciplines are encouraged.
Projects must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative with promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources. The grant application must be
accompanied by letters of support from the Chair of the candidate’s academic department and from the
principal scientific advisor or mentor. These letters are to indicate a general level of support of the
applicant, the fact that the Department will make time, space, and other resources accessible for
completion of the project, and that the applicant will have appropriate supervision/support throughout the
period of the grant. Applicants must obtain letters of support/understanding from all key personnel on the
project.
TERMS
1. Amount: $10,000 maximum
2. Period: 12 months, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

American Head and Neck Society Pilot Grant

Open to Medical Students, residents, PhD, and junior faculty residing in the U.S. and Canada to support basic, translational, or clinical research projects in head and neck oncology. One year, $10,000, one available annually.

The purpose of this award is to support basic, translational, or clinical research projects in head and neck
oncology. Clinical or translational research studies are strongly encouraged and should be specifically
related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck
neoplastic disease.
ELIGIBILITY
Candidates for this award should reside in the U.S. or Canada, be medical students, residents, Ph.D.s or
faculty members at the rank of associate professor or below. Previous AHNS or AAO-HNS Foundation
research grant recipients are eligible to compete for this grant. However, candidates who have
successfully obtained funding from a private or federal funding agency for the same research are
ineligible. Candidates who have applied for support of the same research from other funding sources, and
who are notified of an award from both another agency and from AHNS must choose only one of the
awards.
CONDITIONS
Research supported by this award should be specifically directed toward the pathogenesis,
pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may be
either basic or clinical/translational in approach. While not specifically required, proposals which aim to
introduce new knowledge and methodology from other disciplines to research in head and neck disease,
or which demonstrate collaborative effort with members of other related disciplines are encouraged.
Projects must be designed so as to yield useful information within the period of award, but priority will be
given to projects that are also innovative with promise to develop into new long-range or expanded
research programs capable of attracting funding from other sources.
The grant application must be accompanied by letters of support from the Chair of the candidate’s
academic department and from the principal scientific advisor or mentor. These letters are to indicate a
general level of support of the applicant, the fact that the Department will make time, space, and other
resources accessible for completion of the project, and that the applicant will have appropriate
supervision/support throughout the period of the grant. Applicants must obtain letters of
support/understanding from all key personnel on the project.
TERMS
1. Amount: $10,000 maximum
2. Period: One year, non-renewable

All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time
December 15. The letter of intent includes the title of the project, the principal investigator, and an
abstract of the work. This will facilitate planning review requirements.

The Sidney Kimmel Foundation for Cancer Research utilizes an on-line application available at www. kimmel.org/cancerresearch. Problems or questions about the application process may be address to kfletche@gbmc.org.

Kimmel Scholar Award

To select the grant recipients, the Sidney Kimmel Foundation for Cancer Research has created a Medical Advisory Board consisting of distinguished cancer researchers. Each year the Kimmel Foundation expects to select up to ten grant recipients who will receive $100,000 per year for two years. Qualified applicants must hold an M.D., Ph.D. or equivalent graduate degree and must perform research in an American not-for-profit institution during the period of Kimmel Foundation support.

The Kimmel Foundation is seeking accomplished young investigators dedicated to a career in cancer research. Applications are limited to those who achieved the equivalent rank of Assistant Professor on or after July, 2005. However, physicians who have both clinical and research responsibility are eligible if appointed on or after July, 2004. These awards are designed for researchers who do not yet have their own R01 funding. Applicants will be judged on the basis of quality of prior work, research proposed and letters of support. Funding of awards will be subject to execution of binding agreements setting forth terms and conditions under which scholarships will be provided. Applicants for 2009 awards will be notified by mid-April, 2009.

The Kimmel Translational Science Award

The Foundation provides five additional awards specifically for physicians engaged in translational science. Eligibility includes those with M.D. or equivalent degrees, who have achieved the rank of Assistant Professor on or after July, 2004. Candidates must not hold R01 funding for the laboratory component of their cancer research. Applicants must demonstrate a significant personal involvement in the laboratory component of the translational project described. The translational research may involve primarily animal studies but must include reasonable application to subsequent human investigation.

Each application consists of the following:

Personal Statement (1-2 pages)

Please provide a statement about career objectives as they relate to cancer research and explain how your work satisfies the mission of The Sidney Kimmel Foundation for Cancer Research. The statement should include a description of the work environment and necessary resources available to conduct research and a statement of the approximate percent of effort to be devoted to research, teaching, patient care, administration, and other duties. Be sure to explain how your research will aid our understanding and treatment of human malignant diseases. Attach curriculum vitae.

Research (limit narrative to 3 pages)

Please describe your work in cancer research, including a brief description of pertinent supporting studies. Outline the future direction of current research and include other potential areas of interest. Explain the importance of your work to our understanding of cancer and implications for future therapies of malignant disease or cancer prevention. Graphs, figures, tables and references may be uploaded to the appendix section or included within the narrative.

Budget (1 page)

The Kimmel Scholar Award provides $100,000 per year for two years. The Kimmel Foundation will not provide additional institutional overhead but part of the grant may be budgeted toward overhead costs. The Foundation requests that institutions limit overhead to 15% or less. Please approximate the manner in which funds will be allocated among categories such as salary support, research, equipment, travel, administrative costs, etc. Also describe in detail all other current and pending funding including source, amount and duration of such support. The Foundation will not consider applicants who are already fully funded by R01 grants or who are currently the beneficiary of another similar scholar award which supports cancer research.

Personal References (1-2 pages each)

Please provide three letters of reference. The on-line application will generate a request to your references asking for a letter on your behalf. One letter must be from the Chairman of your Division or Department, and two from appropriate physicians and/or scientists who are familiar with your work. Letters may be sent under separate cover but must be received by December 31. Letters should broadly review the independence and importance of the applicant's work in the context of similar work from other laboratories. Rank the independence and quality of the work, within the reviewer's experience. Assess the overall contribution of the applicant in published papers which involved collaboration with senior investigators.

Appendix

Please supply up to three original papers (authored by applicant) from peer reviewed journals. If available, submit one or more papers or editorials from other sources which elucidate the background or importance of your work (helpful, but not required).

Cover Page (1 page)

Each application should include the standardized cover page, which will be automatically generated upon completion of the on-line application. Please print a copy of the cover page, sign and attach with the hardcopies to be mailed. The cover page should be completed with appropriate demographic information, as requested. Please provide an abstract of the current research and a brief explanatory title. An institutional official who is responsible for budget oversight must also personally sign the cover page for submission to the Foundation. Electronic signatures or copies will not be acceptable.

Completed Applications

The full on-line application should include the standardized cover page, description of research, personal statement, three letters of recommendation, budget and curriculum vitae. Please also supply a signed original and one copy of the application by mail within two days of completed on-line submission. Also include copies of appendix (samples of investigator's and relevant supporting published work). On-line applications must be completed by Wednesday, December 3, 2008 at noon EST. Letters of reference must be submitted preferably by reply email to The Foundation by December 31.

Please submit to:

Gary I. Cohen, M.D.
Cancer Center at GBMC
6569 North Charles Street, Suite 201
Baltimore, MD 21204

Advanced Clinical Research Award

The Advanced Clinical Research Award (ACRA) is designed to provide funding to investigators who are committed to clinical cancer research, and is intended to support original research not currently funded. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. By continuing to support proven clinical researchers at a critical stage in their early career, ASCO hopes to expand the cadre of expert clinical oncology researchers who are developing promising research initiatives.

Current Opportunities:

The ASCO Cancer Foundation 2009 Advanced Clinical Research Award in Breast Cancer
Application open: October 2, 2008
Letter of Intent due: December 4, 2008
Application due: January 8, 2009

The ASCO Cancer Foundation
2318 Mill Road, Suite 800
Alexandria, VA 22314
571.483.1300
Foundation@asco.org

UICC Yamagiwa-Yoshida Memorial international study grants

Target candidates Investigators, clinicians, epidemiologists, public health professionals
Duration 3 months
Extension Up to 3 months with funding secured by the Fellow from other sources and at no cost to UICC
Available 14-16 per year
Average value US$10,000 each
Application closing dates 15 January and 1 July
Notification of result April and October

Note: This is not a clinical training fellowship

Objectives

to initiate, set up or pursue bilateral cancer research projects with collaborating investigators abroad
to exchange and exploit complementary skills and material
to receive training in advanced experimental research methods and techniques

Profile of eligible candidates

appropriate scientific or medical qualifications and a minimum of two years postdoctoral experience
active engagement in cancer research
recent publications in the international peer-reviewed literature

Research plan

basic, translational or applied cancer research
Prevention-oriented projects are especially encouraged

Twice-yearly competitive selections
are conducted by an international panel of experts
based on the scientific evaluation of the research plan the experience and qualifications of the candidate
the suitability of the host organization and host supervisor

appropriate duration
the availability of appropriate facilities and resources to apply and disseminate the acquired skills upon return to the home organization

To contact UICC, write to us at the following address:

International Union Against Cancer (UICC)
62 route de Frontenex
1207 Geneva, Switzerland

Telephone +41 22 809 1811
Fax +41 22 809 1810

CALL FOR NOMINATIONS
The American Academy of Dermatology is pleased to announce a call for nominations for the Lila Gruber Memorial Cancer Research Award and Lectureship.

THE AWARD
The cash award of $10,000 will be made in recognition of the investigator’s lifetime achievements in the field of cancer research. The award has been made possible by a gift from Murray Gruber in memory of his wife. Its purpose is to encourage participation in cancer research and to provide a forum for the enrichment of knowledge of dermatologists in this important scientific field. At the discretion of the Task Force, the award may be divided between two worthy nominees.

THE CRITERIA

* The recipient may be a physician or non-physician scientist of national or International stature whose contributions in the field of cancer research have been outstanding in I importance and distinction.
* The recipient should have proven ability as a communicator, both verbal and written.
* The subject of the lecture should be of general interest to dermatologists.
* Members of the Scientific Assembly Committee are not eligible.

THE SELECTION PROCESS
Requests for nominations will be solicited from the Academy membership at large. The recipient will be selected by the Named Lectureship Task Force and presented to the Scientific Assembly Committee for approval at the planning meeting which is held in the Spring of the year prior to the presentation of the lecture.

Nominations must be submitted to the Task Force no later than Friday, December 5, 2008. The Academy will announce its final decision in August of the following year.

http://www.aad.org/forms/NamedLectureships/Default.aspx?lectureship=3

Linus Pauling Institute Prize for Health Research

The Prize is sponsored by the Linus Pauling Institute at Oregon State University. The LPI functions from the basic premise that an optimum diet and a healthy lifestyle are the key to optimum health. LPI's mission is to determine the function and role of vitamins, essential minerals, and phytochemicals in promoting optimum health and preventing and treating disease; and to determine the role of oxidative/nitrative stress and antioxidants in human health and disease. Major areas of research in the Institute encompass cardiovascular diseases, cancer, aging, and neurodegenerative diseases. The goal of LPI's outreach and education program is to help people everywhere achieve a healthy and productive life, full of vitality, with minimal suffering, and free of cancer and other debilitating diseases. For more information, please visit the Institute's website.

Nature: The Prize consists of $50,000 and a medal, and is awarded biennially. The recipient of the inaugural 2001 Prize was Bruce N. Ames from the University of California, Berkeley, and Children's Hospital Oakland Research Institute. The 2003 Prize went to Harvard University's Walter C. Willett, and the 2005 Prize to Paul Talalay from the Johns Hopkins University School of Medicine. Our 2007 prize winner was Mark Levine from the National Institutes of Health.

Purpose: The Prize recognizes innovation and excellence in research relating to the roles of vitamins, essential minerals, and phytochemicals in promoting optimum health and preventing or treating disease; and the roles of oxidative/nitrative stress and antioxidants in human health and disease. The goal is to stimulate innovative research that enhances our knowledge of the role of diet and lifestyle in the primary and secondary prevention of disease; and the role of oxidative/nitrative stress in disease pathology. The Prize also recognizes successful efforts to disseminate and implement knowledge on diet, lifestyle, and health to enhance public health and reduce suffering from disease.

Procedure: The nominator should submit a nomination letter, two supporting letters solicited from his/her colleagues, and the candidate's up-to-date curriculum vita. The candidate's research accomplishments in light of the purpose of the Prize should be amply described in the letters. The awardee must be present to accept the Prize and deliver a talk at LPI's "Diet and Optimum Health" conference. The next conference will be May 13-16, 2009.

Nomination packages should be sent to:

Barbara McVicar
Linus Pauling Institute
Oregon State University
571 Weniger Hall
Corvallis, OR 97331-6512

Complete nomination materials must be received by November 1, 2008.

Specialized Center of Research Program

The Marshall A. Lichtman Specialized Center of Research (SCOR) program was established to encourage multidisciplinary research focused on the prevention, diagnosis, or treatment of leukemia, lymphoma or myeloma. The program requires synergy among at least three research programs and these programs may be supported by scientific core laboratories. The program permits an application for a competitive renewal of the SCOR grant after five years depending on the progress shown. The program is organized to encourage the interaction of complementary sciences and the linkage of basic sciences to a translational research program.

The center's maximal annual total cost, direct and indirect, cannot exceed $1.25 million. The aggregate costs over five years cannot exceed $6.25 million. The direct costs, if justified by the aggregate budget may be up to $1.042 million per year. The indirect or institutional costs cannot exceed 20 percent of the direct costs per year.

Application Process

A Letter of Intent is due each year via proposalcentral by Nov. 1. Unlike The Leukemia & Lymphoma Society's (LLS) other research programs, SCOR applicants must be invited to submit a full application (after completing a LOI). The invitation to submit a full proposal will be announced by Dec. 31. The full application must be submitted by March 15.

LLS is using proposalCentral for the 2009 SCOR application submission. Investigators and grants officials will be required to register before applying via https://proposalcentral.altum.com/.
The site will open for 2009 award submission by Aug. 31, 2008.

For more program information contact:
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605
Telephone: (914) 821-8843, Christine Kessler; or (914) 821-8290, Sammy Hattar
or
Email: researchprograms@lls.org